#USA #healthcare #Cleveland #Hyland #Digital Pathology

The Future of Pathology: Hyland's Digital Solutions

In the ever-evolving landscape of healthcare, many fields have embraced technological advancements, yet pathology remains largely rooted in traditional practices. Approximately 90% of pathology labs still rely on glass slides, while the diagnostic workload has surged by 42%. This rising demand is leading to unwarranted delays in patient care, costing both individuals and healthcare systems significantly. To address this critical gap, Hyland has introduced Hyland Digital Pathology, a comprehensive solution poised to revolutionize the field.

Bridging the Gaps in Healthcare

For over a decade, sectors such as radiology and cardiology have seen modernization, thanks to innovations that improve efficiency and diagnostic accuracy. Unfortunately, the vast majority of pathology diagnostics continue to depend on outdated methods, which not only hinders progress but also poses risks to patient outcomes. Recognizing the urgent need for transformation, Hyland's Digital Pathology aims to eliminate the last significant barrier to widespread clinical application by delivering a streamlined, digitized platform for the industry.

Vinitha Ramnathan, Senior Vice President and General Manager of Healthcare Product Management at Hyland, emphasized the importance of integrating pathology into a comprehensive medical imaging strategy. She stated, “With Hyland Digital Pathology, we help healthcare systems overcome isolated workflows and connect pathology, radiology, and cardiology within a scalable, centrally managed imaging infrastructure.” This integration is designed to facilitate cross-departmental collaboration, enabling pathology teams to work together more efficiently and making vital diagnostic information readily accessible.

Features of Hyland Digital Pathology

Hyland Digital Pathology utilizes Tribun Health's CaloPix platform, a cutting-edge digital pathology solution authorized by the FDA, licensed by Health Canada, and marked with CE approval. This system preserves familiar diagnostic workflows while confidently promoting faster adoption and reliability in clinical applications. By maintaining essential routines, it minimizes disruptions and fosters confidence among pathologists from the outset.

Jean-François Pomerol, CEO of Tribun Health, remarked that “digital pathology cannot be scaled as an isolated departmental project.” The integration of CaloPix into Hyland's enterprise imaging ecosystem provides a viable pathway for healthcare facilities eager to modernize their pathology services while adhering to the specialized workflows, clinical control measures, and strict regulatory requirements that diagnostic processes demand.

Key components of Hyland Digital Pathology include:

• - CaloPix Image Management System (IMS): A dedicated workflow engine specifically designed for pathology, allowing for primary diagnostics, case management, and AI-supported analyses through a user-friendly interface to accelerate the transition from glass slides to digital solutions.
• - Integration of Medical Imaging: The use of Acuo VNA and NilRead ensures vendor-neutral archiving and multidisciplinary reviews of medical images across various domains like pathology, radiology, and cardiology, allowing seamless data incorporation into collaborative workflows.
• - AI-Enabled and Interoperable: An open, vendor-neutral AI framework with human oversight paves the way for the deployment of AI-assisted diagnostics in health systems, maintaining system coherence without fragmenting infrastructure due to isolated solutions.

Together, these capabilities illustrate a deliberate choice to enhance existing healthcare infrastructures rather than creating yet another siloed archive. Hyland Digital Pathology integrates pathology into a broader strategy for medical imaging, thereby retaining the openness of the systems already in place.

A Platform for Strategic Investment

Hyland's partnership with Tribun Health merges clinical reliability with the scalability of medical imaging solutions, creating a platform that supports millions of imaging procedures across diverse health systems globally. The validated VNA infrastructure of Hyland manages petabyte-scale data volumes linked to Whole-Slide Imaging, ensuring high performance, cost control, and clinical oversight even amidst growing data demand.

The introduction of Hyland Digital Pathology presents three critical outcomes for healthcare systems looking to modernize:
1. Accelerated Clinical Decision-Making: By enabling a quicker transition to digital pathology, the solution retains proven workflows, significantly shortening diagnostic turnaround times while allowing multidisciplinary teams to access pathology and radiology data through a single interface.
2. Support for Pathologists: The solution reduces administrative burdens, fosters telepathology, and enables flexible work models, particularly vital amid growing pathologist shortages, thereby addressing burnout while enhancing staff retention and recruitment.
3. Cost Control: The integration of pathology into a wider medical imaging strategy allows for the reduction of redundant archives, streamlines administrative overhead, and supports intelligent data distribution across storage classes, ensuring that healthcare systems can operate as genuinely integrated entities.

In conclusion, Hyland Digital Pathology represents not just a clinical enhancement but also a financially sound investment for healthcare systems ready to embrace modernization in pathology and fully leverage the potential of integrated diagnostic documentation. Health institutions seeking to transform their pathology services have a compelling partner in Hyland as they chart a course toward a more connected and efficient healthcare future.

Hyland invites attendees of the RSNA 2026 to witness the capabilities of Hyland Digital Pathology firsthand at Booth #1322 in Chicago from November 29 to December 2. For further information about Hyland’s platform and solutions, visit Hyland.com.